Insider · CIK 0001195498

GERMAIN MARK

Reports to the SEC for 5 companies · JERUSALEM

sec.gov

Transactions

Companies

Filings

CIK

0001195498

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-16	SCNIScinai Immunotherapeutics Ltd.A Award	Director	AAward	+120M sh	—	—	120,000,000
2020-09-10	PLURPluri Inc.A Award	Director	AAward	+20K sh	—	—	82,569
2018-12-19	PLURPluri Inc.A Award	Director	AAward	+62.6K sh	—	—	576,569
2018-12-19	PLURPluri Inc.A Award	Director	AAward	+49.1K sh	—	—	625,694
2018-03-16	PLURPluri Inc.S Sale	Director	SSale	−11.6K sh	$1.48	−$17.2K	513,944
2018-03-15	PLURPluri Inc.S Sale	Director	SSale	−34.2K sh	$1.48	−$50.7K	525,584
2018-03-14	PLURPluri Inc.S Sale	Director	SSale	−23.8K sh	$1.50	−$35.7K	559,817
2017-12-14	PLURPluri Inc.A Award	Director	AAward	+131K sh	—	—	583,635
2016-12-29	PLURPluri Inc.A Award	Director	AAward	+65.5K sh	—	—	452,635
2016-01-05	PLURPluri Inc.A Award	Director	AAward	+48K sh	—	—	387,135
2015-01-08	PLURPluri Inc.A Award	Director	AAward	+48K sh	—	—	339,135
2014-03-04	PLURPluri Inc.S Sale	Director	SSale	−67.9K sh	$4.02	−$273K	334,350
2014-01-21	NAGENiagen Bioscience, Inc.A Award	Director	AAward	+10K sh	—	—	10,000
2013-12-26	PLURPluri Inc.A Award	Director	AAward	+65K sh	—	—	402,208
2013-06-27	PLURPluri Inc.A Award	Director	AAward	+50K sh	—	—	337,208
2012-12-21	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	1,046,700
2012-12-21	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−250K sh	—	—	796,700
2012-12-21	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−282K sh	—	—	514,600
2012-12-21	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−282K sh	—	—	232,500
2012-12-21	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−67.5K sh	—	—	165,000
2012-12-21	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−67.5K sh	—	—	97,500
2012-12-21	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)A Award	Director	AAward	+586K sh	—	—	683,524
2012-08-28	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)A Award	Director	AAward	+67.5K sh	—	—	1,076,700
2011-12-21	PLURPluri Inc.A Award	Director	AAward	+90K sh	—	—	287,208
2011-05-18	PLURPluri Inc.A Award	Director	AAward	+42.9K sh	—	—	197,208
2011-05-10	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)A Award	Director	AAward	+67.5K sh	—	—	67,500
2010-10-28	PLURPluri Inc.A Award	Director	AAward	+40K sh	—	—	154,348
2010-05-20	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)A Award	Director	AAward	−282K sh	—	—	282,100
2010-05-20	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)A Award	Director	AAward	−282K sh	—	—	282,100
2010-05-20	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)A Award	Director	AAward	−67.5K sh	—	—	67,500
2010-05-10	PLURPluri Inc.A Award	Director	AAward	+3,648 sh	—	—	114,348
2010-05-10	PLURPluri Inc.A Award	Director	AAward	+3,648 sh	—	—	114,348
2009-12-22	PLURPluri Inc.A Award	Director	AAward	+35K sh	—	—	110,700
2009-05-13	NAGENiagen Bioscience, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2009-05-11	PLURPluri Inc.A Award	Director	AAward	+3,200 sh	—	—	75,700
2009-02-12	PLURPluri Inc.A Award	Director	AAward	+35K sh	—	—	72,500
2009-01-21	PLURPluri Inc. · Stock Option (right to buy)A Award	Director	AAward	+27.5K sh	—	—	27,500
2007-12-17	Reis, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+58.5K sh	$5.81	+$340K	61,744
2007-12-17	Reis, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−58.5K sh	$6.88	−$402K	3,236
2007-12-17	Reis, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+64.9K sh	$5.81	+$377K	68,180
2007-12-17	Reis, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−64.9K sh	$6.88	−$446K	3,236
2007-12-17	Reis, Inc.Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−58.5K sh	—	—	0
2007-12-17	Reis, Inc.Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−64.9K sh	—	—	0
2007-07-02	Reis, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,751 sh	$5.81	+$56.7K	12,987
2007-07-02	Reis, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−9,751 sh	$9.06	−$88.4K	3,236
2007-07-02	Reis, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10.8K sh	$5.81	+$62.9K	14,059
2007-07-02	Reis, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−10.8K sh	$9.06	−$98.1K	3,236
2007-07-02	Reis, Inc.Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,751 sh	—	—	58,508
2007-07-02	Reis, Inc.Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10.8K sh	—	—	64,944
2007-06-20	Reis, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,862 sh	$8.89	+$78.8K	12,098

Recent filings

Accepted (ET)
Jun 184
GERMAIN MARK0001178913-26-003261
SEC(opens sec.gov)
Sep 104
GERMAIN MARK0001213900-20-026095
SEC(opens sec.gov)
Dec 204
GERMAIN MARK0001178913-18-003193
SEC(opens sec.gov)
Mar 194
GERMAIN MARK0001178913-18-000898
SEC(opens sec.gov)
Mar 154
GERMAIN MARK0001178913-18-000854
SEC(opens sec.gov)
Dec 144
GERMAIN MARK0001178913-17-003395
SEC(opens sec.gov)
Dec 294
PLURISTEM THERAPEUTICS INC0001178913-16-007188
SEC(opens sec.gov)
Jan 74
PLURISTEM THERAPEUTICS INC0001178913-16-003925
SEC(opens sec.gov)
Jan 84
PLURISTEM THERAPEUTICS INC0001178913-15-000055
SEC(opens sec.gov)
Mar 54
PLURISTEM THERAPEUTICS INC0001178913-14-000838
SEC(opens sec.gov)
Jan 234
ChromaDex Corp.0001415889-14-000239
SEC(opens sec.gov)
Dec 264
PLURISTEM THERAPEUTICS INC0001178913-13-003733
SEC(opens sec.gov)
Jun 274
PLURISTEM THERAPEUTICS INC0001178913-13-001911
SEC(opens sec.gov)
Dec 264
GERMAIN MARK0001415889-12-001902
SEC(opens sec.gov)

Companies

Address

C/O SCINAI IMMUNOTHERAPEUTICS LTD. JERUSALEM BIOPARK, 2ND FLOOR

JERUSALEM, 9112002